Handbook on Injectable Drugs

In-app purchases
4.5
128 reviews
50K+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image

About this app

“Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.

For over 50 years American Society of Health-System Pharmacists is the most comprehensive reference on injectable drug data. 2024 edition features 400+ monographs on parenteral drugs, 24,500+ compatibility pairs, 3,700+ unique references

5-Star Rating from Doody's Review Service and Doody's Core Titles List Selection
ASHP® Injectable Drug Information™ 2024 content is interactive, mobile, and updated quarterly. Includes monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information..

Key Features
* Quick data search for 358 drugs
* 417 monographs on parenteral drugs available in the United States and in other countries
* Monographs cross-referenced with American Society of Health-System Pharmacists (AHFS) Drug Information through AHFS classification numbers
* More than 500 revisions to existing monographs (affecting 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2024.
* How to prepare, store and administer drugs
* Info accumulated from 3,603 references
* Drugs listed alphabetically by generic name for efficient searching, with brand names listed

WHAT'S NEW
ASHP® Injectable Drug Information™ 2024 includes
* 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries.
* More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and other enhancements to the more than 24,100 compatibility pairs
* The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number.
* While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available.
Content licensed from printed edition ISBN 10: 1585286834
Content licensed from printed edition ISBN 13: 9781585286836

SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.

Yearly auto-renewing payments- $49.99

Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Editor(s): ASHP
Publisher: American Society of Health-System Pharmacists
Updated on
30 May 2024

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region and age The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Personal info
Data isn’t encrypted
You can request that data be deleted

Ratings and reviews

4.4
122 reviews
onco learn
14 March 2024
Amazing app ,kindly I have one hope as we work in NCI and we serve alot of patients so if app team can open all antineplastic and all antimicrobial section only for free content .i will be more thankful
3 people found this review helpful
Did you find this helpful?
Skyscape Medpresso Inc
14 March 2024
Dear User, We are always working to add more sources in the updates. Thank you for sharing your thoughts with us :)
A Google user
20 April 2020
Accurate and simple
40 people found this review helpful
Did you find this helpful?
Skyscape Medpresso Inc
21 April 2020
Thank you so much for your review!
rajabu kimosa
11 June 2020
All over good backup tool
41 people found this review helpful
Did you find this helpful?